Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa J Peart

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cancer Cell|September 9, 2006
Mutant p53 gain of function: the NF-Y connectionMelissa J Peart, Carol Prives
Molecular and Cellular Biology|May 20, 2009
Stxbp4 regulates DeltaNp63 stability by suppression of RACK1-dependent degradationYingchun Li, Melissa J Peart, Carol Prives
Molecular and Cellular Biology|November 5, 2008
Lysine-independent turnover of cyclin G1 can be stabilized by B'alpha subunits of protein phosphatase 2AHongyun Li, Koji Okamoto, Melissa J Peart, et al.
Nature Reviews. Drug Discovery|September 7, 2006
Anticancer activities of histone deacetylase inhibitorsJessica E Bolden, Melissa J Peart, Ricky W Johnstone
Genes & Development|June 3, 2009
A role for Chk1 in blocking transcriptional elongation of p21 RNA during the S-phase checkpointRachel Beckerman, Aaron J Donner, Melissa Mattia, et al.
Cell Cycle (Georgetown, Tex.)|October 16, 2010
APC/C(Cdc20) targets E2F1 for degradation in prometaphaseMelissa J Peart, Masha V Poyurovsky, Elizabeth M Kass, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 2, 2005
Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitorsMelissa J Peart, Gordon K Smyth, Ryan K van Laar, et al.
Blood|December 9, 2008
Defining the target specificity of ABT-737 and synergistic antitumor activities in combination with histone deacetylase inhibitorsKate F Whitecross, Amber E Alsop, Leonie A Cluse, et al.
Cancer Research|August 9, 2003
Novel mechanisms of apoptosis induced by histone deacetylase inhibitorsMelissa J Peart, Kellie M Tainton, Astrid A Ruefli, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cancer Cell|September 9, 2006
Mutant p53 gain of function: the NF-Y connectionMelissa J Peart, Carol Prives
Molecular and Cellular Biology|May 20, 2009
Stxbp4 regulates DeltaNp63 stability by suppression of RACK1-dependent degradationYingchun Li, Melissa J Peart, Carol Prives
Molecular and Cellular Biology|November 5, 2008
Lysine-independent turnover of cyclin G1 can be stabilized by B'alpha subunits of protein phosphatase 2AHongyun Li, Koji Okamoto, Melissa J Peart, et al.
Nature Reviews. Drug Discovery|September 7, 2006
Anticancer activities of histone deacetylase inhibitorsJessica E Bolden, Melissa J Peart, Ricky W Johnstone
Genes & Development|June 3, 2009
A role for Chk1 in blocking transcriptional elongation of p21 RNA during the S-phase checkpointRachel Beckerman, Aaron J Donner, Melissa Mattia, et al.
Cell Cycle (Georgetown, Tex.)|October 16, 2010
APC/C(Cdc20) targets E2F1 for degradation in prometaphaseMelissa J Peart, Masha V Poyurovsky, Elizabeth M Kass, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 2, 2005
Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitorsMelissa J Peart, Gordon K Smyth, Ryan K van Laar, et al.
Blood|December 9, 2008
Defining the target specificity of ABT-737 and synergistic antitumor activities in combination with histone deacetylase inhibitorsKate F Whitecross, Amber E Alsop, Leonie A Cluse, et al.
Cancer Research|August 9, 2003
Novel mechanisms of apoptosis induced by histone deacetylase inhibitorsMelissa J Peart, Kellie M Tainton, Astrid A Ruefli, et al.
Pageof 1